| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antimetastatic effect of a lipophilic ascorbic acid derivative with antioxidation through inhibition of tumor invasion
|
Liu, Jianwen
|
|
2005
|
57 |
5 |
p. 584-590
|
artikel
|
| 2 |
Antitumor activity of erlotinib in combination with capecitabine in human tumor xenograft models
|
-Ouchi, Kaori F.
|
|
2005
|
57 |
5 |
p. 693-702
|
artikel
|
| 3 |
A phase I clinical pharmacologic study of pralatrexate in combination with probenecid in adults with advanced solid tumors
|
Fury, Matthew G.
|
|
2005
|
57 |
5 |
p. 671-677
|
artikel
|
| 4 |
A phase I study of monohydroxyethylrutoside in healthy volunteers
|
Willems, Anja M.
|
|
2005
|
57 |
5 |
p. 678-684
|
artikel
|
| 5 |
Clinical and pharmacokinetic study evaluating the effect of food on the disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in patients with solid tumors
|
Zamboni, William C.
|
|
2005
|
57 |
5 |
p. 631-639
|
artikel
|
| 6 |
CYP1A1 activation of aminoflavone leads to DNA damage in human tumor cell lines
|
Pobst, Lori J.
|
|
2005
|
57 |
5 |
p. 569-576
|
artikel
|
| 7 |
Failure of neutrophil chemotactic function in breast cancer patients treated with chemotherapy
|
Mendonça, Maria Angélica O.
|
|
2005
|
57 |
5 |
p. 663-670
|
artikel
|
| 8 |
High efficacy of gemcitabine and cisplatin in patients with predominantly anthracycline- and taxane-pretreated metastatic breast cancer
|
Heinemann, V.
|
|
2005
|
57 |
5 |
p. 640-646
|
artikel
|
| 9 |
Lack of effect of ketoconazole-mediated CYP3A inhibition on sorafenib clinical pharmacokinetics
|
Lathia, Chetan
|
|
2005
|
57 |
5 |
p. 685-692
|
artikel
|
| 10 |
Oral vinorelbine alone or in combination with trastuzumab in advanced breast cancer: results from a pilot trial
|
Bartsch, Rupert
|
|
2005
|
57 |
5 |
p. 554-558
|
artikel
|
| 11 |
Pegylated liposomal doxorubicin in combination with gemcitabine: a phase II study in anthracycline-naïve and anthracycline pretreated metastatic breast cancer patients
|
Fabi, Alessandra
|
|
2005
|
57 |
5 |
p. 615-623
|
artikel
|
| 12 |
Pharmacokinetic and cytotoxic studies of pegylated liposomal daunorubicin
|
Song, Haifeng
|
|
2005
|
57 |
5 |
p. 591-598
|
artikel
|
| 13 |
Pharmacokinetic changes induced by the volume of chemotherapy solution in patients treated with hyperthermic intraperitoneal mitomycin C
|
Sugarbaker, Paul H.
|
|
2005
|
57 |
5 |
p. 703-708
|
artikel
|
| 14 |
Pharmacokinetics and biodistribution of the camptothecin–polymer conjugate IT-101 in rats and tumor-bearing mice
|
Schluep, Thomas
|
|
2005
|
57 |
5 |
p. 654-662
|
artikel
|
| 15 |
Phase I/II dose escalation study of angiotensin 1-7 [A(1-7)] administered before and after chemotherapy in patients with newly diagnosed breast cancer
|
Rodgers, Kathleen E.
|
|
2005
|
57 |
5 |
p. 559-568
|
artikel
|
| 16 |
Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer
|
Okusaka, Takuji
|
|
2005
|
57 |
5 |
p. 647-653
|
artikel
|
| 17 |
Plasma kinetics of a cholesterol-rich microemulsion (LDE) in patients with Hodgkin’s and non-Hodgkin’s lymphoma and a preliminary study on the toxicity of etoposide associated with LDE
|
Pinheiro, Ketlin V.
|
|
2005
|
57 |
5 |
p. 624-630
|
artikel
|
| 18 |
Preclinical pharmacology of the novel antitumor agent adaphostin, a tyrphostin analog that inhibits bcr/abl
|
Li, Mao
|
|
2005
|
57 |
5 |
p. 607-614
|
artikel
|
| 19 |
Role of mitochondria as the gardens of cell death
|
Kim, Ryungsa
|
|
2005
|
57 |
5 |
p. 545-553
|
artikel
|
| 20 |
Thalidomide does not interact with P-glycoprotein
|
Zimmermann, Christian
|
|
2005
|
57 |
5 |
p. 599-606
|
artikel
|
| 21 |
The MMP-9 expression determined the efficacy of postoperative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer
|
Ogata, Yutaka
|
|
2005
|
57 |
5 |
p. 577-583
|
artikel
|
Tijdschrift beschrijving